1. Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. Issue 5 (May 2022) Authors: Hussain, Syed A; Lester, Jason F; Jackson, Richard; Gornall, Matthew; Qureshi, Muneeb; Elliott, Anthony; Crabb, Simon J; Huddart, Robert A; Vasudev, Naveen; Birtle, Alison J; Worlding, Jane; James, Nicholas D; Parikh, Omi; Vilarino-Varela, Maria; Alonzi, Roberto; Linch, Mark D; Riaz, Irbaz B; Cat... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗